You just read:

Actinium Pharmaceuticals to Present New Clinical Findings from SIERRA Trial Supporting the Iomab-ACT Program for Targeted Lymphodepletion for CAR-T and Adoptive Cell Therapies at ASH 2019

News provided by

Actinium Pharmaceuticals, Inc.

Nov 06, 2019, 09:00 ET